Lack of Usefulness of Donor-Derived Cell-Free DNA as a Biomarker for Cardiac Allograft Vasculopathy: A Prospective Study

BackgroundCardiac allograft vasculopathy (CAV) remains a major cause of morbidity and mortality among long-term heart transplant recipients. There is an unmet need for a non-invasive biomarker of CAV that could obviate the need to perform surveillance coronary angiograms in these patients. Our aim w...

Full description

Bibliographic Details
Main Authors: Marta Jiménez-Blanco Bravo, Laura Pérez-Gómez, Francisco J. Hernández-Pérez, Carlos Arellano-Serrano, Mario Torres-Sanabria, Manuel Gómez-Bueno, Juan F. Oteo-Domínguez, Susana Mingo-Santos, Javier Segovia-Cubero
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.856600/full